Lumos Labs, announced today that the FDA has granted 510(k) clearance for LumosityRx, a prescription digital therapeutic for adults with ADHD.

Half of prisoners in London are believed to have undiagnosed attention deficit hyperactivity disorder ( ADHD ), according to ...

Lumos Labs has gained US Food and Drug Administration (FDA) clearance for LumosityRx, a prescription digital therapeutic (PDT) that aims to improve attention span in adult patients with attention ...

A study of 8,300+ children found even modest social media use gradually increased ADHD-like inattention, while TV and video ...

LumosityRx is a prescription therapeutic app that includes 13 cognitive training games targeting key brain processes connected to attention function.

Adults with autism spectrum disorder (ASD) and other neurodevelopmental disorders (NDDs) often lose access to specialized ...

Offering screening for neurodivergence to people detained by the police could help ensure access to appropriate support and ...

Offering screening for neurodivergence to people detained by the police could help ensure access to appropriate support and fairer treatment in the criminal justice system, say Cambridge researchers, ...

Offering screening for neurodivergence to people detained by the police could help ensure access to appropriate support and fairer treatment in the ...

I deliberately detoured from the damage to the brain by blood sugar overload to recall the painful demise of Chioma Isabella ...

Good luck with your difficult life,' says my Dad, rather sadly, as he hugs me goodbye. I can sense the disappointment that ...

Children born to mothers with prepregnancy obesity face a higher risk for neurodevelopmental disorders (ie, epilepsy and intellectual disability).